Vaccinium corymbosum

From WikiMD's WELLNESSPEDIA

(Redirected from Northern highbush blueberry)

Vaccinium corymbosum in bloom

Vaccinium corymbosum, commonly known as the northern highbush blueberry, is a species of Vaccinium native to eastern North America. It is an important commercial fruit crop and is widely cultivated for its sweet, edible berries.

Description[edit]

Vaccinium corymbosum is a deciduous shrub that typically grows to a height of 1.5 to 3 meters. The leaves are simple, ovate to elliptical, and measure 3 to 8 cm in length. They are dark green in color and turn red or purple in the fall.

The flowers are bell-shaped, white to pale pink, and appear in clusters in the spring. The fruit is a berry, 5 to 16 mm in diameter, that ripens to a deep blue color. The berries are sweet and rich in antioxidants.

Habitat and Distribution[edit]

This species is native to the eastern United States and Canada, from Maine to Florida, and west to Minnesota and Louisiana. It thrives in acidic soils and is commonly found in wetlands, bogs, and forests.

Cultivation[edit]

Vaccinium corymbosum is widely cultivated for its fruit, which is consumed fresh, frozen, or processed into products such as jams, jellies, and juices. It requires acidic soil with a pH of 4.5 to 5.5 and benefits from mulching and irrigation.

Several cultivars have been developed to improve yield, fruit size, and disease resistance. Popular cultivars include 'Bluecrop', 'Jersey', and 'Duke'.

Uses[edit]

The berries of Vaccinium corymbosum are rich in vitamin C, vitamin K, and dietary fiber. They are also a source of anthocyanins, which are believed to have health benefits.

In addition to their nutritional value, the berries are used in traditional medicine for their purported anti-inflammatory and antioxidant properties.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.